Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of using digital technology to monitor adherence to inhaled therapies and health status in pwCF.

This is a protocol.

Health topics:

Insurance medicine > Sick Leave > Genetic disorders

Insurance medicine > Sick Leave > Lungs & airways

Published:

16 September 2020

Authors:

Smith S, Calthorpe R, Herbert S, Smyth AR

Primary Review Group:

Cystic Fibrosis and Genetic Disorders Group

See the full Review on

the Cochrane Library

►

Print
PDF
Citation
Smith S, Calthorpe R, Herbert S, Smyth AR. Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013733. DOI: 10.1002/14651858.CD013733.

Don't show again

What role do you identify with the most?

General public, patient, or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.